Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- Check3 days agoChange DetectedThe record history now shows a new revision (v3.6.3) replacing the previous v3.6.2. This indicates a minor platform update rather than a content change on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision label v3.6.2 was added and the previous v3.6.0 label removed, indicating a backend/UI update to the history display rather than changes to the trial data.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record now shows that recruitment is closed (no longer looking for participants) and includes a new revision tag v3.6.0 in the history.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page history now includes a new revision label v3.5.5, replacing the previous v3.5.4, indicating the study record has been updated.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer revision label was updated from v3.5.3 to v3.5.4. This indicates a new revision of the page was published.SummaryDifference0.1%

- Check67 days agoChange DetectedThe Record History now shows a new revision entry (v3.5.3) replacing the previous v3.5.2, indicating an administrative update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.